ArTS Archivio della ricerca di Trieste

POZZATO, GABRIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.223
EU - Europa 9.115
AS - Asia 6.337
SA - Sud America 1.109
AF - Africa 142
OC - Oceania 36
Continente sconosciuto - Info sul continente non disponibili 18
Totale 33.980
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.015
SG - Singapore 2.287
PL - Polonia 1.827
CN - Cina 1.731
UA - Ucraina 1.577
SE - Svezia 1.207
IT - Italia 1.136
HK - Hong Kong 1.079
BR - Brasile 911
DE - Germania 740
FI - Finlandia 611
RU - Federazione Russa 410
GB - Regno Unito 331
KR - Corea 290
IE - Irlanda 287
FR - Francia 286
BG - Bulgaria 277
TR - Turchia 274
VN - Vietnam 234
CA - Canada 122
NL - Olanda 119
IN - India 105
AR - Argentina 69
CH - Svizzera 65
JP - Giappone 59
MX - Messico 59
BE - Belgio 56
BD - Bangladesh 49
MA - Marocco 44
PK - Pakistan 44
EC - Ecuador 35
AT - Austria 30
ES - Italia 30
AU - Australia 28
IQ - Iraq 27
ZA - Sudafrica 27
CO - Colombia 23
RO - Romania 23
EG - Egitto 22
ID - Indonesia 22
CZ - Repubblica Ceca 20
IR - Iran 20
CL - Cile 18
VE - Venezuela 18
PY - Paraguay 15
EU - Europa 14
SN - Senegal 14
JO - Giordania 13
SA - Arabia Saudita 12
TN - Tunisia 11
TW - Taiwan 11
GR - Grecia 10
PT - Portogallo 10
KE - Kenya 9
LU - Lussemburgo 9
UZ - Uzbekistan 9
DK - Danimarca 8
HR - Croazia 8
UY - Uruguay 8
IL - Israele 7
KZ - Kazakistan 7
NO - Norvegia 7
PE - Perù 7
PH - Filippine 7
AE - Emirati Arabi Uniti 6
AZ - Azerbaigian 5
BY - Bielorussia 5
KG - Kirghizistan 5
LT - Lituania 5
TT - Trinidad e Tobago 5
HN - Honduras 4
JM - Giamaica 4
NP - Nepal 4
NZ - Nuova Zelanda 4
OM - Oman 4
PA - Panama 4
RS - Serbia 4
BO - Bolivia 3
DZ - Algeria 3
EE - Estonia 3
GE - Georgia 3
LK - Sri Lanka 3
MY - Malesia 3
PS - Palestinian Territory 3
SI - Slovenia 3
SY - Repubblica araba siriana 3
A1 - Anonimo 2
ET - Etiopia 2
GD - Grenada 2
GY - Guiana 2
HU - Ungheria 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
MK - Macedonia 2
MO - Macao, regione amministrativa speciale della Cina 2
NR - Nauru 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AP - ???statistics.table.value.countryCode.AP??? 1
BA - Bosnia-Erzegovina 1
Totale 33.950
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.961
Ann Arbor 1.823
Warsaw 1.808
Fairfield 1.530
Jacksonville 1.392
Houston 1.377
Ashburn 1.270
Chandler 1.253
Singapore 1.095
Hong Kong 1.070
Wilmington 876
Hefei 636
Seattle 573
Princeton 536
Cambridge 506
Boardman 430
Beijing 360
Trieste 332
Seoul 285
Dublin 283
Sofia 276
Columbus 263
Munich 257
Izmir 239
Dallas 210
Moscow 186
Los Angeles 154
Buffalo 132
Helsinki 112
Santa Clara 108
Düsseldorf 103
Dearborn 101
San Diego 99
São Paulo 83
The Dalles 81
Ho Chi Minh City 77
Chicago 64
London 59
Redwood City 59
Milan 58
Bern 56
New York 51
Frankfurt am Main 50
Brussels 49
Toronto 48
Phoenix 43
Hanoi 41
Norwalk 41
Verona 40
Turku 35
Shanghai 34
Rio de Janeiro 32
Redondo Beach 31
Casablanca 30
Dong Ket 30
Guangzhou 29
Tianjin 29
Des Moines 28
Kunming 28
Jinan 27
Sacile 27
Mestre 26
Tokyo 26
Ottawa 25
Falls Church 24
Nanjing 23
Padova 23
Belo Horizonte 22
Brooklyn 21
Denver 21
Duino-Aurisina 21
Grafing 21
Nuremberg 20
Washington 20
Boston 19
Chennai 19
Montreal 18
Stockholm 18
Venezia 18
Mumbai 17
Vienna 17
Bremen 16
Johannesburg 15
Lahore 15
North Bergen 15
Quito 15
Roubaix 15
Zhengzhou 15
Atlanta 14
Baghdad 14
Dakar 14
Brno 13
Fremont 13
Portsmouth 13
Redmond 13
San Francisco 13
Shenyang 13
Amman 12
Amsterdam 12
Brasília 12
Totale 23.577
Salva come PNG Salva come JPEG
Nome #
KRAS, NRAS, and BRAF mutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survival 447
MBL2 Genetic Variants in HCV Infection Susceptibility, Spontaneous Viral Clearance and Pegylated Interferon Plus Ribavirin Treatment Response 438
Polymer-mediated delivery of siRNAs to hepatocellular carcinoma: Variables affecting specificity and effectiveness 433
Potential applications of nanocellulose-containing materials in the biomedical field 418
Targeted tumor imaging of anti-CD20-polymeric nanoparticles developed for the diagnosis of B-cell malignancies 416
Hepatitis C virus and non-Hodgkin's lymphomas: Meta-analysis of epidemiology data and therapy options. 383
NOTCH1 mutations associate with low CD20 level in chronic lymphocytic leukemia: Evidence for a NOTCH1 mutation-driven epigenetic dysregulation 367
Iodine-based contrast media, multiple myeloma and monoclonal gammopathies: literature review and ESUR Contrast Media Safety Committee guidelines 350
Usefulness of core needle biopsy for the diagnosis of thyroid Burkitt's lymphoma: a case report and review of the literature 318
Mutations in the 3' untranslated region (3' UTR) of NOTCH1 are associated with low CD20 expression levels in chronic lymphocytic leukemia 316
Targeting CD34+ cells of the inflamed synovial endothelium by guided nanoparticles for the treatment of rheumatoid arthritis 297
Survival and Prognostic Factors in Mixed Cryoglobulinemia: Data from 246 Cases 293
New Potential Therapeutic Approach for the Treatment of B-Cell Malignancies Using Chlorambucil/Hydroxychloroquine-Loaded Anti-CD20 Nanoparticles. 272
The role of the transcription factor E2F1 in hepatocellular carcinoma 258
Strategies to optimize siRNA delivery to hepatocellular carcinoma cells 251
Serum Response Factor depletion affects the proliferation of the hepatocellular carcinoma cells HepG2 and JHH6 249
Novel Lipid and Polymeric Materials as Delivery Systems for Nucleic Acid Based Drugs 240
A new approach for the treatment of CLL using chlorambucil/hydroxychloroquine-loaded anti-CD20 nanoparticles 233
Bortezomib arrests the proliferation of hepatocellular carcinoma cells HepG2 and JHH6 by differentially affecting E2F1, p21 and p27 levels. 219
CD209 promoter polymorphisms associate with HCV infection and pegylated-interferon plus ribavirin treatment response 219
Translation Elongation 216
13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia. 210
Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia. 209
Dissecting the role of the elongation factor 1A isoforms in hepatocellular carcinoma cells by liposome-mediated delivery of siRNAs 207
Detection of TP53 dysfunction in chronic lymphocytic leukemia by an in vitro functional assay based on TP53 activation by the non-genotoxic drug Nutlin-3: a proposal for clinical application. 206
Impairment of the Pin1/E2F1 axis in the anti-proliferative effect of bortezomib in hepatocellular carcinoma cells 206
Aptamer targeting of the elongation factor 1A impairs hepatocarcinoma cells viability and potentiates bortezomib and idarubicin effects 206
Diagnostic and prognostic role of eEF1A in chronic lymphocytic leukaemia 204
NOTCH1-mutated chronic lymphocytic leukemia cells are characterized by a MYC-related overexpression of nucleophosmin 1 and ribosome-associated components 203
Metastatic angioimmunoblastic T-cell lymphoma started from thoracic paravertebral region: a Case report 201
Effects of E2F1-cyclinE1-E2 circuit down-regulation in hepatocellular carcinoma cells 198
CD49d is overexpressed by trisomy 12 chronic lymphocytic leukemia cells: evidence for a methylation-dependent regulation mechanism. 196
A case of burkitt-like B lymphoblastic lymphoma 195
Haemochromatosis gene mutations in a clustered Italian population: evidence of high prevalence in people of Celtic ancestry. 193
DEFB1 polymorphisms and salivary hBD-1 concentration in Oral Lichen Planus patients and healthy subjects 190
Aptamers as nano-targeting delivery devices or anti-cancer drugs for fighting tumours 188
Blood flow changes in hepatocellular carcinomas after the administration of Thaliodomide by reperfusion kinetics during microbubble infusion: Preliminary results. 187
Impact of DEFB1 gene regulatory polymorphisms on hBD-1 salivary concentration 186
Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemia 180
A transient cutaneous relapse of AML M1 in hematological remission: A case report 180
A siRNA targeted against SRF reduce hepatocellular carcinoma cell proliferation, showing its potential use in the growth inhibition of this type of tumor 178
S-adenosylmethionine counteracts oral contraceptive hepatotoxicity in women 175
Galactosylated polyaspartamide copolymers for siRNA targeted delivery to hepatocellular carcinoma cells 173
ARHGDIA, a mutant TP53-associated Rho GDP dissociation inhibitor, is over-expressed in gene expression profiles ofTP53disrupted chronic lymphocytic leukaemia cells 171
A siRNA targeted against SRF reduce hepatocellular carcinoma cell proliferation, showing its potential use in the growth inhibition of this type of tumor 170
B-cell receptor, clinical course and prognosis in chronic lymphocytic leukaemia: the growing saga of the IGHV3 subgroup gene usage. 168
Improving siRNA Bio-Distribution and Minimizing Side Effects 165
Evaluation of the contribution of the elongational factor 1 A isoforms in hepatocellular carcinoma celss growth 165
A new genotype: typical of Italy? 163
HLA-G regulatory polymorphisms are associated with susceptibility to HCV infection 163
Introduction 163
Effects of eEF1A1 targeting by aptamer/siRNA in chronic lymphocytic leukaemia cells 162
Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials 160
Hematologic problems in the Critically III 156
Persistent CD49d engagement in circulating CLL cells: a role for blood-borne ligands? 155
A randomized trial comparing different alfa-interferon at different dose and duration as therapy for chronic hepatitis C. 154
The SIRT1/TP53 axis is activated upon B-cell receptor triggering via miR-132 up-regulation in chronic lymphocytic leukemia cells 153
Abnormality in the hepatic transport of Rifamycin-SV in Gilbert's syndrome 152
Influence of acid-secretion blockers on gastric and hepatic alcohol dehydrogenase in rat 152
No evidence of Polyomavirus and EBV infections in Italian patients with mixed cryoglobulinemia infected chronically with HCV 151
DEVELOPMENT OF CHLORAMBUCIL/HYDROXYCHLOROQUINE-LOADED ANTI-CD20 NANOPARTICLES FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA : IN VITRO MODEL 151
5-Azacytidine Downregulates the Proliferation and Migration of Hepatocellular Carcinoma Cells In Vitro and In Vivo by Targeting miR-139-5p/ROCK2 Pathway 151
null 150
Merkel-cell polyomavirus and B-cell chronic lymphocytic leukemia 147
Acute high-dose ethanol modulates glutathione levels to different degrees in various organs of the rat. 147
ALCOHOL HEPATIC TOXICITY IN RAT: EVIDENCE OF THE UTILITY OF THE GASTRIC ETHANOL METABOLISM 146
Abnormal serum gamma-glutamyltranspeptidase in alcoholics: clues to its explanation 146
Long-term effects of the new direct antiviral agents (DAAs) therapy for HCV-related mixed cryoglobulinaemia without renal involvement: a multicentre open-label study 146
Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders. 145
Randomized trial of combination therapy in relapser or non-responder HCV patients 145
CD49d prevails over the novel recurrent mutations as independent prognosticator of overall survival in chronic lymphocytic leukemia. 145
The CD49d/CD29 complex is physically and functionally associated with CD38 in B-cell chronic lymphocytic leukemia cells 144
Typing hepatitis C virus by polymerase chain reaction with type-specific primers: relationship to the severity of liver disease and response to the alpha-interferon therapy. 143
Effects of chlorambucil/hydroxychloroquine-loaded anti-CD20 nanoparticles on a human/mouse model of Burkitt lymphoma 143
A multicentre randomized clinical trial of recombinant alpha-2a interferon therapy in patients with chronic hepatitis B 142
Different genotypes of hepatitis C virus are associated with different severity of chronic liver disease 140
Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: a pilot study. 139
Reversal of intrahepatic cholestasis of pregnancy in women after high dose S-adenosyl-L-methionine administration. 138
Systematic review of purine analog treatment for chronic lymphocytic leukemia: lessons for future trials 138
BCR signaling inhibitors differ in their ability to overcome Mcl-1-mediated resistance of CLL B cells to ABT-199 138
Bortezomib effect of E2F and cyclin family members in human hepatocellular carcinoma cell lines 137
Human leucocyte interferon-alpha in the treatment of chronic hepatitis C 136
Aptamers as targeting delivery devices or anti-cancer drugs for fighting tumors 136
A novel animal model to study non-spontaneous bisphosphonates osteonecrosis of jaw. 134
Treatment with interferon(s) of community-acquired chronic hepatitis and cirrhosis type C. 133
B-Lymphocyte stimulator (BLyS) up-regulation in mixed cryoglobulinemia syndrome and hepatitis-C virus infection 133
Influence of ascitic fluid characteristics on coagulation disorders after implantation of Le Veen peritoneo-jugular shunt. 133
SiRNAs targeted against cyclin E1, cyclin E2 and E2F1 down regulate the growth of Hepatocellular Carcinoma showing their potential use in the prevention of this type of tumor 132
Quantitative analysis of hepatitis C virus RNA in liver biopsies by competitive reverse transcription and polymerase chain reaction. 131
Comparable functions of plasmacytoid and monocyte-derived dendritic cells in chronic hepatitis C patients and healthy donors. 130
Gastric and hepatic glutathione after ethanol load: the role of first-pass metabolism and effects of antisecretive drugs. 130
IGHV gene mutational status and 17p deletion are independent molecular predictors in a comprehensive clinical-biological prognostic model for overall survival prediction in chronic lymphocytic leukemia. 130
Pegylated-interferon plus ribavirin for HCV-positive indolent non-Hodgkin lymphomas 130
The targeting of the elongation factor 1A by a DNA aptamer impairs the viability of hepatocarcinoma cells 129
"True" histiocytic lymphoma of the stomach associated with colonic cancer and complicated by chronic myeloid leukemica 128
HEPATIC GLUTATHIONE AFTER ETHANOL ADMINISTRATION IN RAT: EFFECTS OF CIMETIDINE AND OMEPRAZOLE. 127
Severity of liver disease with different hepatitis C viral clones. 126
Low-grade malignant lymphoma, hepatitis C virus infection and mixed cryoglobulinemia. 125
Role of E2F1-cycline1-cycline2 circuit in hepatocellular carcinoma cell proliferation and therapeutic potential of its down-regulation by siRNAs 123
Xenograft zebrafish models for the development of novel anti-hepatocellular carcinoma molecules 123
Totale 19.117
Salva come PNG Salva come JPEG
Categoria #
all - tutte 105.728
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 105.728
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.997 0 0 0 0 0 424 146 353 127 437 119 391
2021/20222.722 71 235 151 344 42 156 100 139 367 304 166 647
2022/20233.443 376 378 295 454 374 646 29 263 406 36 125 61
2023/20242.013 165 132 84 98 159 154 296 503 21 63 162 176
2024/20254.890 117 144 308 392 412 464 353 373 824 618 398 487
2025/20264.603 858 691 915 995 1.004 140 0 0 0 0 0 0
Totale 34.569